Recruiting NA Visual Field Defect

New treatment option for Visual Field Defect

Official title Home-based Vision Rehabilitation Guided by Brain Imaging

ClinicalTrials.gov ID: NCT07635329

What this study is testing

What it's testing
The BRIGHT (Behavioral Rehabilitation Through Image-Guided Home-based Training) study aims to evaluate the effectiveness of image-guided, home-based perceptual training at improving visual performance in individuals with visual field loss. Using a prospective, crossover design, BRIGHT combines visual behavioral testing, neuroimaging, and a home-based intervention.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • At least 18 years of age.
  • Capable of providing informed consent and complying with study procedures.
  • Unilateral or bilateral focal brain damage causing visual field loss.
  • At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year.
  • Eligible for MRI based on standard safety screening.

You likely can't join if

  • Severe neurological or psychiatric conditions unrelated to the focal lesion that may interfere with study participation or data interpretation.
  • Current or recent (within the past 6 months) drug or alcohol abuse or addiction as defined by DSM-5.
  • Ocular disease or disorder.

The study team makes the final eligibility decision.

Where it's taking place

  • Washington D.C., District of Columbia, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Washington D.C., District of Columbia, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.